Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Deubiquitinase USP9X loss sensitizes renal cancer cells to mTOR inhibition.
Roldán-Romero JM, Valdivia C, Santos M, Lanillos J, Maroto P, Anguera G, Calsina B, Martinez-Montes A, Monteagudo M, Mellid S, Leandro-García LJ, Montero-Conde C, Cascón A, Roncador G, Coloma J, Robledo M, Rodriguez-Antona C. Roldán-Romero JM, et al. Among authors: maroto p. Int J Cancer. 2023 Sep 15;153(6):1300-1312. doi: 10.1002/ijc.34575. Epub 2023 Jun 1. Int J Cancer. 2023. PMID: 37260183
What About Variant Histologies in Bladder Cancer?
Day E, Gavira J, Tapia JC, Anguera G, Maroto P. Day E, et al. Among authors: maroto p. Eur Urol Focus. 2024 Mar;10(2):227-230. doi: 10.1016/j.euf.2024.05.015. Epub 2024 Jun 6. Eur Urol Focus. 2024. PMID: 38849276 Review.
Growing teratoma syndrome: experience of a single institution.
Maroto P, Tabernero JM, Villavicencio H, Mesía R, Marcuello E, Solé-Balcells FJ, Sola C, Mora J, Algaba F, Pérez C, León X, López López JJ. Maroto P, et al. Eur Urol. 1997;32(3):305-9. Eur Urol. 1997. PMID: 9358218
Bone Marrow Transplantation: Prognostic Factors of Peripheral Blood Stem Cell Mobilization with Cyclophosphamide and Filgrastim (r-metHuG-CSF): The CD34+ Cell Dose Positively Affects the Time to Hematopoietic Recovery and Supportive Requirements after High-Dose Chemotherapy.
Solá C, Maroto P, Salazar R, Mesía R, Mendoza L, Brunet J, López-Pousa A, Tabernero JM, Montesinos J, Pericay C, Martínez C, Cancelas JA, López-López JJ. Solá C, et al. Among authors: maroto p. Hematology. 1999;4(3):195-209. doi: 10.1080/10245332.1999.11746443. Hematology. 1999. PMID: 11399564 Free article.
114 results